Ecological Momentary Assessment of Smoking Triggers, Needs, and Cigarette Forgoing (spark Forgo)

September 28, 2026 updated by: Amanda L. Rebar, University of South Carolina

This study will evaluate a smartphone-based program designed to support adults who smoke cigarettes. Participants will use the spark app to complete brief surveys during the day and a daily evening survey about their smoking urges, smoking, decisions not to smoke, and everyday experiences. Participants will also log cigarettes when they smoke. After some cigarette logs, participants will answer a few additional questions about their situation and feelings; after others, they will only log the cigarette.

The study has three phases. In the first phase, participants will complete surveys and cigarette logs without receiving intervention messages. In the second phase, they will receive motivational messages at random times. In the third phase, message timing and content will be tailored using information collected during the earlier phases. The study will examine whether personalized motivational messages can help participants forgo smoking in daily life.

Study Overview

Detailed Description

This study uses a within-person, phased ecological momentary assessment (EMA) and ecological momentary intervention (EMI) design to characterize momentary factors associated with cigarette smoking and smoking forgoing and to evaluate non-adaptive and adaptive motivational messaging delivered via the *spark* smartphone platform.

During all study phases, participants will complete four randomly timed EMA assessments per day during predefined waking hours and a daily evening survey. EMA assessments will assess momentary contextual factors, including current activity or routine, physical environment, social context, affective and cognitive states, smoking urges or craving, cigarette use since the previous assessment, and instances in which a smoking urge occurred without smoking (i.e., smoking forgoing). Evening surveys will assess daily smoking-related attitudes, cognitions, and behaviors.

Participants may also initiate an event-contingent entry whenever they smoke a cigarette. Each self-initiated entry will record the smoking event. Following each cigarette log, the app will randomly assign, with equal probability, whether the participant completes additional questions about the smoking context and feeling states or only logs the cigarette. To minimize assessment burden, randomly timed EMA prompts will not be delivered until at least one hour after completion of a self-initiated cigarette survey.

The study includes three phases. During the EMA Observation Phase, participants will complete EMA assessments, evening surveys, and event-contingent cigarette logs; no intervention messages will be delivered. During the Non-Adaptive EMI Phase, participants will continue these assessments and receive motivational messages delivered at randomly selected times, without tailoring to participant behavior or context. During the Adaptive EMI Phase, participants will continue all assessments and receive motivational messages at times determined by predictive models developed using data from the first two phases. Message content will be adapted based on the estimated likelihood of successful smoking forgoing in response to momentary contexts and internal states.

Where technically feasible and permitted by participant consent, passive smartphone-based data may be collected, including geolocation-derived patterns, time-stamped device-activity indicators, and environmental-context variables such as local weather conditions. These data will be used to enhance characterization of contextual factors associated with smoking urges, smoking behavior, smoking forgoing, and responsiveness to motivational intervention delivery.

Study Type

Interventional

Enrollment (Estimated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 21 years or older.
  • Has smoked at least 100 cigarettes in their lifetime.
  • Currently smokes cigarettes every day.
  • Smokes 10 or fewer cigarettes per day.
  • Owns a compatible smartphone with reliable internet access and is willing to install and use the *spark* study application.
  • Able to read and understand English.
  • Willing and able to complete smartphone-based assessments, self-initiated cigarette-event logs, and daily evening surveys for the study duration.
  • Able and willing to provide informed consent.

Exclusion Criteria:

  • Current use of electronic cigarettes or vaping products.
  • Unable to provide informed consent.
  • Does not have a compatible smartphone or reliable internet access.
  • Unable to complete study procedures because of a cognitive, visual, motor, or other impairment not accommodated by the study procedures.
  • Currently enrolled in another smoking-cessation intervention study that would conflict with study participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single Group (EMA/EMI sequence)

All participants complete three phases in sequence: an EMA Observation Phase with no intervention messages; a Non-Adaptive EMI Phase with randomly timed motivational messages; and an Adaptive EMI Phase with motivational messages timed and tailored using predictive models. Participants complete EMA and evening surveys throughout and may self-initiate cigarette-event logs.

Smartphone-delivered motivational messages provided at randomly selected times during the Non-Adaptive EMI Phase. Message timing and content are not tailored using participant behavior, context, or assessment data.

Smartphone-delivered motivational messages provided during the Adaptive EMI Phase. Message timing is determined using predictive models developed from earlier study-phase data, and message content is adapted to the participant's estimated likelihood of successfully forgoing smoking in their current context.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of weekly smoking urge episodes in which smoking is forgone
Time Frame: During the 21-day study period

Smoking forgoing will be assessed using study-specific ecological momentary assessment (EMA) item: "Since the last prompt (check-in or smoking report), have you *chosen* to skip any cigarettes that you normally would have smoked?" (yes/no). The outcome is the percentage of participant-reported smoking urge episodes per week. Higher percentages indicate more smoking forgoing.

During the 21-day study period
Number of cigarettes smoked per day
Time Frame: During the 21-day study period

Cigarette smoking will be assessed using count of the participant-initiated cigarette-event logs. The outcome is the mean number of cigarettes smoked per participant per week during the study period.

During the 21-day study period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean weekly momentary smoking urge/craving intensity score
Time Frame: During the 21-day study period

Current smoking urge or craving will be assessed using a study-specific EMA item: "How much do you crave (have an urging for) a cigarette right now? ". Participants will rate urge/craving on a 1-7 point scale, where 1 = 'not at all' and 7 = 'very much'. Higher scores indicate greater urge/craving.

During the 21-day study period
Weekly EMA adherence
Time Frame: Throughout the study (week 1, 2, and 3).

Proportion of scheduled EMA prompts completed by participants per week

Throughout the study (week 1, 2, and 3).
Smoking forgoing following motivational-message delivery
Time Frame: During the two bouts of 7-day Non-Adaptive EMI and Adaptive EMI phases of the 21-day study period.

Smoking-forgoing will be assessed using study-specific EMA urge reports and participant-initiated cigarette-event logs. The outcome is the percentage of participant-reported smoking-urge episodes in which the participant does not smoke a cigarette, calculated separately following delivery versus non-delivery of a motivational message at eligible decision points. Higher percentages indicate greater smoking forgoing.

During the two bouts of 7-day Non-Adaptive EMI and Adaptive EMI phases of the 21-day study period.
Cigarette smoking following motivational-message delivery
Time Frame: During the two bouts of 7-day Non-Adaptive EMI and Adaptive EMI phases of the 21-day study period.

Cigarette smoking will be assessed using count of participant-initiated cigarette-event logs. The outcome is the mean number of cigarettes smoked per participant per week, calculated separately following delivery versus non-delivery of a motivational message at eligible decision points.

During the two bouts of 7-day Non-Adaptive EMI and Adaptive EMI phases of the 21-day study period.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 20, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

September 1, 2027

Study Registration Dates

First Submitted

September 15, 2026

First Submitted That Met QC Criteria

September 28, 2026

First Posted (Actual)

October 1, 2026

Study Record Updates

Last Update Posted (Actual)

October 1, 2026

Last Update Submitted That Met QC Criteria

September 28, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because the intensive, time-stamped ecological momentary assessment data and potential passive smartphone data may create a risk of participant re-identification. Data will be retained and managed in accordance with the approved protocol, informed-consent materials, institutional policies, and applicable regulations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe